Abnormal Echocardiography 7 Days after Stem Cell Transplantation May Be an Early Indicator of Thrombotic Microangiopathy

作者：Dandoy Christopher E^*; Davies Stella M; Hirsch Russel; Chima Ranjit S; Paff Zachary; Cash Michelle; Ryan Thomas D; Lane Adam; El Bietar Javier; Myers Kasiani C; Jodele Sonata

来源：Biology of Blood and Marrow Transplantation, 2015, 21(1): 113-118.

DOI：10.1016/j.bbmt.2014.09.028

• Pulmonary hypertension
• Pericardial effusion
• Left ventricle depression
• Thrombotic microangiopathy
• Echocardiography
• Hematopoietic stem cell transplantation

Cardiac complications after hematopoietic stem cell transplantation (HSCT) can lead to significant morbidity and mortality. Cardiac evaluation during the first 100 days after HSCT is usually performed only if clinically indicated, and no studies have examined whether routine screening is beneficial in this patient population at high risk for tissue injury. We conducted a single-center prospective clinical study to screen for cardiac complications in pediatric and young adult patients. One hundred consecutive HSCT patients underwent scheduled echocardiographic screening on day +7 after transplantation, independent of their clinical condition. At least 1 abnormality was identified in 30% of cases. Seventeen children had a pericardial effusion, 13 elevated right ventricular pressure, and 3 reduced left ventricular function. Survival was reduced in children with any echocardiographic abnormality at day 7 (67% versus 80% in those with and without, respectively, abnormality, P = .073). Moreover, raised right ventricular pressure at day +7 was significantly associated with transplant-associated thrombotic microangiopathy (TA-TMA; P = .004) and may indicate early vascular injury in the lungs. These data suggest that echocardiography 7 days after HSCT can detect early cardiac complications of HSCT and may identify early vascular injury associated with TA-TMA.

• 出版日期2015-1